Ever since its early roots, the US has been a key player in the pharmaceutical industry, with prominent names like Pfizer, Eli Lilly and Bristol Myers Squibb (BMS) all becoming market pioneers in the ...
The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This combination is setting the stage for ...
John F. Crowley is president and CEO of the Biotechnology Innovation Organization. Kendalle Burlin O’Connell is CEO and president of MassBio. As nearly 20,000 scientists, executives, investors, ...
China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results